![Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024](https://oncodaily.com/pub/uploads/2024/06/GQhLPcYW0AEGMnC-e1719848817606-1280x960.jpeg)
Photo from Rodrigo Sánchez-Bayona/X
Jul 1, 2024, 13:29
Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital, posted on X:
“Thanks to The European Society for Medical Oncology for the Merit Travel Grant to present our RWE study of ovarian cancer patients treated with PARP inhibitors in Spain, a young oncologist collaborative research, in ESMO Gynaecological Cancers Congress 2024.”
Source: Rodrigo Sánchez-Bayona/X